The learning medical professional

 CD40 agonist antibodies are immunotherapy agents designed to activate the CD40 receptor on antigen-presenting cells (dendritic cells, B cells), boosting anti-tumor immune responses. They convert "cold" tumors "hot" (immune-active), enhancing T cell activation and enabling tumor regression, often used in combination with chemotherapy or checkpoint inhibitors.  Clinical Potential: They have shown promise in treating cancers like pancreatic cancer, melanoma, and mesothelioma by inducing significant tumor regressions. Example of CD40 agonists in clinical development include selicrelumab (CDX-1127),  New version. 2141-V11 is an Fc-engineered, agonistic antibody targeting the human CD40 receptor. Designed to stimulate the immune system, it is currently under investigation as a therapeutic agent for metastatic cancers.  Mechanism of Action: Unlike standard anti-CD40 antibodies, 2141-V11 is engineered to enhance binding to the inhibitory receptor FcγRIIB. When administered...

 The recent use of USAG-1 (Uterine Sensitization Associated Gene-1) protein inhibition for stimulating tooth growth represents a significant advancement in regenerative dentistry. This method, developed by Japanese scientists, leverages monoclonal antibodies to target USAG-1, which interacts with BMP (Bone Morphogenetic Protein) and Wnt signaling pathways—critical regulators of tooth and organ development. By disrupting USAG-1's interaction with BMP, researchers have successfully promoted tooth growth in animal models like mice and ferrets, paving the way for future human applications​ ImpactLab ​ University of Fukui . Past approaches in regenerative dentistry and similar therapies have explored the following: Stem Cell Therapies : These focus on regenerating dental pulp or enamel using stem cells harvested from various tissues, including baby teeth or bone marrow. Although promising, challenges remain in directing cell differentiation and integration​ University of Fukui . Tissue ...

A Harvard study has found t hat private equity hospitals faced significant cuts in staffing and salaries, especially in the emergency departments and ICUs, compared to non-acquired hospitals. It suggested that these might be behind the increased mortality. Ref https://timesofindia.indiatimes.com/science/mortality-in-hospitals-rises-after-private-equity-takeover-says-harvard-study/articleshow/124088785.cms

 Google’s medical AI just cited a fake body part in research, sparking serious concerns. Google is facing backlash from the medical community after its healthcare AI model, Med-Gemini, invented a non-existent human body part in a published research paper.  The AI described an “old left basilar ganglia infarct” — an anatomical impossibility, likely caused by confusing the real basal ganglia with the basilar artery.  Board-certified neurologist Bryan Moore flagged the error, prompting Google to quietly correct its blog post but not the original paper.  While Google attributed the mistake to a simple typo learned from training data, experts say it highlights the dangers of AI “hallucinations” in high-stakes fields like medicine, where fabricated details could cause serious harm if left unchecked. Healthcare professionals warn that the incident underscores a broader problem: even advanced “reasoning” AI models like Med-Gemini — and its successor, MedGemma — can produce c...

Comprehensive classification of AI/LLM user types and their mental development context. With Ref to News: MIT researchers have discovered that using ChatGPT for essay writing reduces brain engagement and learning over time. Through EEG brain scans of 54 students, those who relied on AI performed worse than others across neural and linguistic metrics. The study raises concerns that AI tools may hinder critical thinking and promote passive acceptance of algorithm-driven content. https://economictimes.indiatimes.com/magazines/panache/is-chatgpt-making-us-dumb-mit-brain-scans-reveal-alarming-truth-about-ais-impact-on-the-human-mind/articleshow/121955720.cms?from=mdr A. Classification of AI/LLM Users and Their Cognitive Profiles We can classify users of AI/LLMs (Large Language Models) across two broad segments: students and working professionals , with further subcategories based on age, academic stage, and cognitive expectations. 1. Students a. Classes 9–10 (Ages ~14–16): This group...